1. S L I D E 0
Embryonic Development of the Kidney
Ibrahim Sandokji
2. S L I D E 1
A 3-month-old, preterm, male infant born at 36 weeks presents for
evaluation of small kidneys incidentally noted on abdominal
ultrasonography performed when the infant presented with emesis to the
emergency department. His prenatal course was complicated by
intrauterine growth restriction. There is no family history of renal disease.
Physical examination findings are normal, with a blood pressure of 80/50
mm Hg. Renal ultrasonography reveals a left kidney of 3.6 cm and right
kidney of 3.5 cm (<2 SDs below the mean).
Of the following, the MOST likely cause of small kidneys in this infant is
A. intrauterine growth restriction
B. maternal vitamin A deficiency
C. PAX2 mutation
D. prematurity
3. S L I D E 2
The parents of a 19 mo boy with unilateral renal agenesis are
expecting another baby. They are curious if their next baby will
have the same problem and wonder when the kidneys start to form.
You tell them:
a) The first signs of the kidney (the metanephros) appear very
early on, in the 5th week of gestation
b) The lower urinary tract forms first. A ureteric bud will first
branch off the early "bladder;" it ascends and takes until the
2nd trimester for it to start forming the kidney
c) Rudimentary kidneys called the pronephros and subsequently
the mesonephros are present for the first 8 — 12 weeks. The
permanent kidney (metanephros) does not form until these
involute
d) The fetal kidney cannot be detected until urine starts to form,
in the early 2nd trimester
4. S L I D E 3
You are studying a medication that when given to pregnant
women, seems to negatively impact fetal nephrogenesis. In
creating an animal model, you must recognize
a) Branching of the ureteric bud occurs independently from
tubulogenesis and mesenchymal-to-epithelial transition
b) The ureteric bud develops into the future calyces, renal pelvis,
and ureter, but otherwise does not develop into any part of the
renal tubular system
c) Inner (deeper) nephrons form first, and development proceeds
outwardly such that outer cortical nephrons are the last to
complete development
d) Nephrogenesis starts slowly and gradually increases to its peak
rate between the 30-36 weeks' gestation
5. S L I D E 4
You are consulted on an infant whose mother was taking an ACE
inhibitor during her pregnancy. Which of the following is a
complication of exposure to ACE inhibitors during embryogenesis?
a) Vesicoureteral reflux
b) Renal Hypo-dysplasia
c) Multicystic Dysplastic Kidney
d) Posterior Urethral Valves
6. S L I D E 5
Your Maternal Fetal Medicine colleagues consult you on a baby with
bilateral renal agenesis. There was some amniotic fluid earlier on in
the pregnancy but on the 20 week ultrasound there is anhydramnios.
This can be explained because
a) Urine production commences in mid/late 1st trimester, though
doesn't become the major source of amniotic fluid until the 2nd
trimester
b) Urine production doesn't begin until the 2nd trimester, so this
explains how the anhydramnios is a more recent development
c) The mesonephros was contributing to the urine production in the
first trimester, but as that involuted, anhydramnios developed
d) The kidneys must have formed initially, and they subsequently
involuted
7. S L I D E 6
Stages of Kidney Development
Kher et al (2016). Clinical Pediatric Nephrology, 3rd Edition
9. S L I D E 8
The parents of a 19 mo boy with unilateral renal agenesis are
expecting another baby. They are curious if their next baby will
have the same problem and wonder when the kidneys start to form.
You tell them:
a) The first signs of the kidney (the metanephros) appear very
early on, in the 5th week of gestation
b) The lower urinary tract forms first. A ureteric bud will first
branch off the early "bladder;" it ascends and takes until the
2nd trimester for it to start forming the kidney
c) Rudimentary kidneys called the pronephros and subsequently
the mesonephros are present for the first 8 — 12 weeks. The
permanent kidney (metanephros) does not form until these
involute
d) The fetal kidney cannot be detected until urine starts to form,
in the early in the 2nd trimester
10. S L I D E 9
Nephron development
• The ureteric bud tips induce the surrounding metanephric
mesenchyme to undergo a transition to epithelial cells
(mesenchymal-epithelial transition)
• The epithelial cells aggregate to form a condensation and a sphere
of cells known as the renal vesicle
• The vesicle then undergoes a series of morphologic changes to
become a comma, and then an S-shape.
11. S L I D E 10
Stages of Renal Morphogenesis
Kher et al (2016). Clinical Pediatric Nephrology, 3rd Edition
12. S L I D E 11
Defects in Ureteric Bud Outgrowth or Branching
13. S L I D E 12
Signaling Pathways Regulating Ureteric Bud Outgrowth and Branching
Kher et al (2016). Clinical Pediatric Nephrology, 3rd Edition
Townes
Brocks
syndrome
Branchiootorenal
Syndrome
Renal
Coloboma
syndrome
Renal
Aplasia
Renal
hypoplasia
14. S L I D E 13
Mutations Exhibiting Defects in Renal Morphogenesis
15. S L I D E 14
Development of Renal Vasculature
Kher et al (2016). Clinical Pediatric Nephrology, 3rd Edition
16. S L I D E 15
Development of Renal Vasculature and Kidneys Ascend
17. S L I D E 16
• Ureteric bud branching and nephron induction continue until 28 to
36 weeks’ gestation
• Nephron number is established at birth (if FT)
• LBW and IUGR are associated with decreased nephron number
• Studies of premature infants (<36 wk) indicate that although some
new nephrons form after birth, nephron formation terminates
early, leading to low nephron number
• Low nephron number -> proteinuria and chronic kidney disease
18. S L I D E 17
Relationship Between Nephron Formation and Gestational Age
Solid line: nephron number
Dashed line: renal mass
19. S L I D E 18
Compensatory Hypertrophy
• In the setting of a poorly functioning or atrophic kidney,
compensatory growth in the contra-lateral kidney is seen
• Unilateral nephrectomy at birth in rats leads to hypertrophy and
hyperplasia (not increased numbers of nephrons)
• Hypertrophy may begin in utero
21. S L I D E 20
Urine Production
• It begins in the 9th-10th weeks gestation
• Fetal urine steadily becomes the major source of amniotic fluid by
the second trimester (20 weeks onwards)
• Oligohydramnios/Anhydramnios-> Potter's Sequence
22. S L I D E 21
Your Maternal Fetal Medicine colleagues consult you on a baby with
bilateral renal agenesis. There was some amniotic fluid earlier on in
the pregnancy but on the 20 week ultrasound there is anhydramnios.
This can be explained because
a) Urine production commences in mid/late 1st trimester, though
doesn't become the major source of amniotic fluid until the 2nd
trimester
b) Urine production doesn't begin until the 2nd trimester, so this
explains how the anhydramnios is a more recent development
c) The mesonephros was contributing to the urine production in the
first trimester, but as that involuted, anhydramnios developed
d) The kidneys must have formed initially, and they subsequently
involuted
23. S L I D E 22
Maternal and Perinatal Factors Associated with Defects in
Ureteric Bud Branching and Renal Anomalies
24. S L I D E 23
• A 3-month-old, preterm, male infant born at 36 weeks presents for
evaluation of small kidneys incidentally noted on abdominal
ultrasonography performed when the infant presented with emesis to
the emergency department. His prenatal course was complicated by
intrauterine growth restriction. There is no family history of renal
disease. Physical examination findings are normal, with a blood
pressure of 80/50 mm Hg. Renal ultrasonography reveals a left kidney
of 3.6 cm and right kidney of 3.5 cm (<2 SDs below the mean).
Of the following, the MOST likely cause of small kidneys in this infant is
A. intrauterine growth restriction
B. maternal vitamin A deficiency
C. PAX2 mutation
D. prematurity
26. S L I D E 25
Clinical Indicators to Search for a Renal Anomaly
Denis et al (2008). Pediatric Kidney Disease, second edition
27. S L I D E 26
You are consulted on an infant whose mother was taking an ACE
inhibitor during her pregnancy. Which of the following is a
complication of exposure to ACE inhibitors during embryogenesis?
a) Vesicoureteral reflux
b) Renal Hypo-dysplasia
c) Multicystic Dysplastic Kidney
d) Posterior Urethral Valves
28. S L I D E 27
Congenital Abnormalities of the Kidney and Urinary Tract
(CAKUT)
• Spectrum of developmental urologic and renal abnormalities
• Previously believed to arise from urinary obstruction
• Now believed that genetic defects -> disrupt critical signaling
processes between the ureteric bud and nephrogenic mesenchyme
29. S L I D E 28
Nonsyndromic human congenital anomalies of the
kidney and urinary tract (CAKUT)
Song (2011) Pediatr Nephrol
30. S L I D E 29
You are studying a medication that when given to pregnant
women, seems to negatively impact fetal nephrogenesis. In
creating an animal model, you must recognize
a) Branching of the ureteric bud occurs independently from
tubulogenesis and mesenchymal to epithelial transition
b) The ureteric bud develops into the future calyces, renal pelvis,
and ureter, but otherwise does not develop into any part of the
renal tubular system
c) Inner (deeper) nephrons form first, and development proceeds
outwardly such that outer cortical nephrons are the last to
complete development
d) Nephrogenesis starts slowly and gradually increases to its peak
rate between the 30-36 weeks' gestation
31. S L I D E 30
Summary
• There are 3 primitive kidneys that form during human kidney
development:
Pronephros -> Mesonephros -> Metanephros
• The ureteric bud reciprocally induces the metanephric
mesenchyme -> branching morphogenesis -> immature
nephrons (comma- and S-shaped bodies) -> mature nephrons with
a fully developed tubular system.
• This process starts at approximately the 5th week and ends at
approximately the 36th week of gestation.
• Defects in ureteric bud outgrowth and branching can lead to
congenital abnormalities of the kidney and urinary tract.
36. S L I D E 35
Molecular basis for the early formation of the
metanephros and ureter
Editor's Notes
Ureteric bud outgrowth from the wolffian duct is modulated by factors secreted by the metanephric blastema and the mesoderm surrounding the duct (1). Morphologic intermediates formed during nephrogenesis consist of condensation of the metanephric cap around the ureteric bud branch (2) renal vesicle comma shape (3), S shape (4), elongation of the tubule (5), invasion of blood vessels into the glomeruli, and formation of the glomerular corpuscle (6)
Defects in ureteric bud (UB) outgrowth or branching result in renal anomalies (MM=metanephric mesenchyme)
Pax2: transcription factor
Eya1: transcription factor
GDNF: growth factor
RET: the GDNF receptor
Gene products that control cellular events and induction of the ureteric bud in the wolffian duct. Mesenchymal cells at the caudal end of the nephrogenic cord (light blue cell) express various factors that activate expression of glial-derived neurotrophic factor (GDNF). In addition, mesenchymal cells release gremlin-1 (GREM1), an inhibitor of bone morphogenetic protein (BMP) signaling, and other still unidentified factors. Released GDNF binds to RET and GDNF-family receptor α1 (GFRA1) receptors that are on the epithelial cells of the mesonephric duct (wolffian duct). The combination of these signals induces ureteric budding. Mesenchymal cells at a more rostral level (dark blue cell) express forkhead box protein C1 (FOXC1), slit homologue 2 (SLIT2), and its receptor roundabout homologue 2 (ROBO2), leading to a repression of GDNF. In epithelial cells of the mesonephric duct, the tyrosine kinase inhibitor sprouty 1 (Spry1) suppresses RET activation. Finally, BMP4 also inhibits ureter outgrowth. EYA1, eyes-absent homologue 1; GDF11, growth differentiation factor-11; HOX11, homeobox protein 11; NPNT, nephronectin; WT1, Wilms tumor transcription factor.
The first vessels are capillaries at the stalk of the ureteric bud. The next vessels to form are the glomerular capillaries” endothelial cells migrate into the cleft of the S-shaped nephron -> form the fenestrated glomerular epithelium.
Ascend: elongation of the ureters + decrease in body curvature + growth in lumbosacral regions.
Early -> branches of the common iliac arteries
As the kidneys ascend -> branches from the distal aorta -> then -> abdominal aorta
Normally, the distal branches disappear, and the abdominal branches become the permanent renal arteries.
In the preterm infant, nephrogenesis continues after birth but is subject to damage by diseases and drugs.
Schematic representation of the relationship between nephron formation and gestational age during human fetal renal development. Renal branching morphogenesis, a principal determinant of nephron number (solid line), is complete by midgestation. Renal mass (dashed line) increases exponentially in the latter half of gestation through the additional induction of new nephrons and hypertrophy of existing nephrons. Blue shading represents postnatal period.
Although mechanisms have not been completely understood for all factors:
Angiotensin II stimulates ureteric bud branching + nephrogenesis + renal vasculature development
Maternal vitamin A deficiency likely affects Ret expression
In this patient, intrauterine growth restriction is the most likely cause of the small kidneys because the infant has a history of intrauterine growth retardation, which is associated with renal hypoplasia. In the absence of family history or abnormal physical findings, a PAX2 mutation (associated with autosomal dominant renal-coloboma syndrome and renal hypoplasia) is less likely in this infant. Although prematurity can lead to a decreased nephron number, this infant was only mildly premature (36 weeks’ gestation), at which time ureteric bud branching is complete. Maternal vitamin A deficiency is associated with renal hypoplasia but is more likely in an underdeveloped country.
(a) Early induction of metanephros. (b) Branching of ureteric bud. (c) Early tubule formation. FGF, fibroblast growth factor; GDNF, glial cell line-derived neurotrophic factor; LIF, leukemia inhibitory factor.